Transforming Concept Elaboration in COA Localization: A Gen AI Based Approach

Author(s)

Johnson M1, Sas Olesa E2, Agüero F3, Bodzer A3, Nolte K(3, O'Gara L3, Casale S3, Costa S3, Elizondo Jimenez K3
1Lionbridge Technologies, Cary, NC, USA, 2Lionbridge Technologies, Dun Laoghaire, D, Ireland, 3Lionbridge Technologies, Waltham, MA, USA

OBJECTIVES: The localization of Clinical Outcome Assessment (COA) measures, particularly through Linguistic Validation, has traditionally been a discipline highly reliant on human activities. Recognizing the great potential for progress with current GenAI capabilities, we set out to streamline the Concept Elaboration process by automating it further with the use of GenAI. Our ultimate goal was to test this technology’s capability to improve efficiency and thereby save time and costs in the overall project schedule, while balancing the outputs for completeness and quality via human review.

METHODS: Following our initial literature review on the topic, we performed a qualitative analysis on the Concept Elaboration outputs of multiple COAs of different types and complexity levels generated by a secure GenAI engine. During the investigation, prompts were customized until a suitable output was obtained, in line with the latest COA industry standards and established practices.

RESULTS: Preliminary results of the analysis performed on our sample instruments suggest that, given the right tailor-made prompt, GenAI can successfully perform the extraction of key terminology and can even go a step further to define such concepts within the context of the therapeutic area and disease being evaluated.

CONCLUSIONS: GenAI offers valuable insights to support the Concept Elaboration step and, when customized with the right input, also provides a considerable efficiency improvement in the Linguistic Validation process. Furthermore, during our analysis, it became evident that the GenAI applications can be further extended, as the scope of Concept Elaboration is interdependent with Source Analysis and Translatability Assessment. Therefore, with GenAI support, they have great potential to be merged into one single activity, further condensing the steps needed to perform the full localization process of COAs.

Conference/Value in Health Info

2024-11, ISPOR Europe 2024, Barcelona, Spain

Value in Health, Volume 27, Issue 12, S2 (December 2024)

Code

CO149

Topic

Clinical Outcomes, Methodological & Statistical Research, Patient-Centered Research

Topic Subcategory

Artificial Intelligence, Machine Learning, Predictive Analytics, Clinical Outcomes Assessment, Instrument Development, Validation, & Translation, Patient-reported Outcomes & Quality of Life Outcomes

Disease

No Additional Disease & Conditions/Specialized Treatment Areas

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×